How do I write a SOAP note for a 65-year-old male with hypertension and chronic heart failure presenting with bilateral lower-leg pitting edema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

SOAP Note for Bilateral Lower-Leg Pitting Edema in CHF Patient

For a 65-year-old male with hypertension and chronic heart failure presenting with bilateral lower-leg pitting edema, document volume overload as the primary problem, initiate or uptitrate loop diuretics (at least double the home dose if already on diuretics), and optimize guideline-directed medical therapy including ACE inhibitors/ARBs and beta-blockers.

Subjective Section

Document the following specific elements:

Symptom Characteristics:

  • Duration and progression of leg swelling (hours vs. days/weeks)
  • Presence of dyspnea (at rest, with exertion, orthopnea, paroxysmal nocturnal dyspnea) 1
  • Decreased exercise tolerance or fatigue
  • Weight gain pattern (>3-4 lbs in 3-4 days is clinically significant) 1
  • Abdominal distention, right upper quadrant discomfort
  • Reduced urine output

Medication History:

  • Current diuretic dose and compliance
  • ACE inhibitor/ARB dose
  • Beta-blocker dose
  • Recent medication changes
  • Use of NSAIDs (contraindicated) 2

Contributing Factors:

  • Dietary sodium intake
  • Fluid intake patterns
  • Recent hospitalizations for heart failure 3

Objective Section

Physical Examination Findings - Document at least 2:

  • Peripheral edema: Grade the pitting edema (1-4+) in feet, ankles, legs, presacral area 1
  • Jugular venous pressure: Elevated JVP and/or hepatojugular reflux 1
  • Pulmonary findings: Bilateral basilar rales/crackles 1
  • Cardiac findings: S3 gallop, displaced point of maximal impulse 1
  • Weight: Current weight and comparison to baseline/dry weight 1
  • Vital signs: Blood pressure (critical for treatment decisions), heart rate, respiratory rate

Laboratory Data (obtain within 24 hours):

  • BNP or NT-proBNP (typically >500 pg/mL or >2000 pg/mL respectively in acute decompensation) 1
  • Serum creatinine and BUN (baseline renal function)
  • Electrolytes (sodium, potassium, chloride)
  • Serum albumin (to assess oncotic pressure and nutritional status) 4

Additional Studies:

  • Chest X-ray if pulmonary congestion suspected
  • Echocardiogram data (ejection fraction, filling pressures if available)

Assessment Section

Primary Diagnosis:

  • Acute decompensated heart failure with volume overload (specify HFrEF if EF <40%)
  • NYHA functional class (II, III, or IV based on symptoms)

Contributing Factors:

  • Chronic heart failure with reduced ejection fraction
  • Hypertension (controlled vs. uncontrolled)
  • Medication non-adherence vs. inadequate diuretic dosing
  • Dietary indiscretion (sodium/fluid intake)

Severity Assessment:

  • Hemodynamic profile: "wet and warm" (most common - 70-75% of patients) 4
  • Risk stratification based on presentation blood pressure (higher SBP associated with better outcomes) 5

Plan Section

Immediate Management

Diuretic Therapy (Essential for symptomatic relief):

If hospitalized or requiring IV therapy:

  • For patients on chronic oral diuretics: Start IV furosemide at at least 2-2.5× the total daily oral dose 4, 6, 7
    • Example: If on furosemide 40 mg daily → start 80-100 mg IV
  • For diuretic-naive patients: Start furosemide 20-40 mg IV 7
  • Administer as intermittent boluses or continuous infusion (both equally effective) 7
  • Monitor: Urine output, daily weights, symptoms, renal function, and electrolytes 7

If outpatient management appropriate:

  • Increase oral loop diuretic dose
  • Consider twice-daily dosing if inadequate response 2
  • If GFR <30 mL/min: Use loop diuretics, avoid thiazides except synergistically with loops 2

Adjunctive Diuretic Therapy (if insufficient response):

  • Combine loop diuretic with thiazide-type diuretic 2, 7
  • Consider adding metolazone in severe cases with frequent creatinine/electrolyte monitoring 2

Guideline-Directed Medical Therapy Optimization

ACE Inhibitors (First-line therapy):

  • If not on ACE inhibitor: Initiate at low dose, uptitrate to target doses from major trials 2
  • Always combine with diuretics 2
  • Monitor BP, renal function, and electrolytes at 1-2 weeks after dose changes, then at 3 months, then every 6 months 2
  • Avoid potassium-sparing diuretics during ACE inhibitor initiation 2

Beta-Blockers:

  • Continue in stable patients (improves outcomes in HFrEF) 2
  • May need temporary dose reduction if hypotensive

Mineralocorticoid Receptor Antagonists:

  • Consider adding if hypokalemia persists after ACE inhibitor initiation 2
  • Start low dose, check potassium and creatinine after 5-7 days 2

Monitoring Plan

Short-term (during diuresis):

  • Daily weights (target 1-2 kg/day fluid loss)
  • Urine output monitoring
  • Renal function and electrolytes every 2-3 days initially
  • Accept modest creatinine increases (up to 50% from baseline) if transient and accompanied by successful decongestion 4
  • Target BNP/NT-proBNP reduction of ≥30% before discharge (associated with better outcomes) 4

Decongestion Goals:

  • Resolution of orthopnea and dyspnea
  • JVP normalization (may need adjustment if right-left heart pressure mismatch) 4
  • Elimination of peripheral edema (may need to relax goal if chronic venous insufficiency or low albumin present) 4
  • Return to dry weight

Patient Education and Non-Pharmacological Management

Dietary Modifications:

  • Sodium restriction (especially in severe heart failure) 2
  • Fluid restriction in severe HF 2
  • Avoid excessive alcohol 2

Self-Monitoring:

  • Daily weights at same time (report gain >3-4 lbs in 3-4 days) 2
  • Symptom recognition and when to seek care 2

Activity:

  • Maintain daily physical activity in stable patients to prevent deconditioning 2
  • Rest not encouraged in stable conditions 2

Follow-up

  • Reassess in 1-2 weeks if outpatient management
  • Consider hospitalization if: severe symptoms, hypotension, significant renal dysfunction, or inadequate outpatient response
  • Long-term follow-up every 3-6 months once stable

Critical Pitfalls to Avoid

  • Do not withhold diuretics due to modest creatinine elevation if patient remains congested - transient worsening renal function during effective diuresis is acceptable and associated with better outcomes 4
  • Do not use NSAIDs - they antagonize diuretic effects and worsen heart failure 2
  • Do not add potassium-sparing diuretics during ACE inhibitor initiation - risk of hyperkalemia 2
  • Do not undertitrate diuretics - persistent congestion worsens outcomes more than transient renal dysfunction 4

References

Guideline

kidney dysfunction in heart failure: core curriculum 2025.

American Journal of Kidney Diseases, 2025

Related Questions

Why would diastolic blood pressure be elevated in a patient with heart failure?
What are the differential diagnoses for bilateral leg swelling?
In a 61-year-old man with hypertension, a 30‑pack‑year smoking history, and 2‑day exertional dyspnea with only basal crackles, which laboratory test is most specific and helpful for diagnosing heart failure?
Is benzonate (Tessalon) safe for patients with hypertension and congestive heart failure?
What are the recommended starting doses and monitoring parameters for benazepril (ACE inhibitor), metolazone (thiazide-like diuretic), and bumetanide (loop diuretic) in a patient with hypertension or heart failure?
What is the therapeutic dose of apixaban (Eliquis) for an adult with acute axillary‑vein deep‑vein thrombosis?
In chronic heart failure, which is more important for prognosis: exercise capacity and absence of heart‑failure symptoms, or laboratory and echocardiographic parameters?
At what body‑mass index (BMI) should a stimulant be discontinued in an underweight adult?
What alternative statins can be used for a patient with statin-associated muscle symptoms, including lower‑potency options and dosing strategies?
What empiric therapy should be started for a patient with a cloudy urine sample, positive nitrite, many bacteria, elevated creatinine (1.36 mg/dL), leukocytosis (neutrophils 22,650/µL), and a pending urine culture?
What is the target international normalized ratio (INR) for patients with mechanical aortic, mitral, or combined heart valves?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.